ArticleHuman brain mapping2025
Neural Correlates of Peripheral Inflammation in Major Depressive Disorder and Their Transcriptomic Architecture, Neurochemical Basis, and Behavioral Relevance.
Article in Human brain mapping, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Cortical morphometric gradients reveal molecular and cognitive underpinnings of bipolar disorder.Psychological medicine · 2025Article
- Neural Correlates of Peripheral Inflammation in Major Depressive Disorder and Their Transcriptomic Architecture, Neurochemical Basis, and Behavioral Relevance.Human brain mapping · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The role of inflammation in the neuropathology of major depressive disorder (MDD) is evident. However, the neural correlates of peripheral inflammation in MDD and their transcriptomic architecture, neurochemical basis, and behavioral relevance have not been systematically investigated. We adopted functional and diffusion magnetic resonance imaging to assess gray matter function and white matter integrity, whose associations with serum C-reactive protein (CRP) levels were explored in a large sample of MDD patients. Further, we examined the spatial relationships of the identified neural correlates of CRP with transcriptome, neurotransmitter, and behavioral domain atlases. Higher serum CRP levels were associated with local gray matter function alterations and widespread white matter integrity changes in MDD patients, but not HC. Moreover, the gray matter functional correlates of CRP in MDD were spatially correlated with functional gene categories involving inflammatory signaling pathways (macrophage activation, NF-κB signaling, and JUN kinase activity), specific neurotransmitters (serotonin, GABA, and glutamate), and diverse behavioral domains (sensorimotor, cognition, emotion, and sleep). In addition, some neural correlates of CRP (anterior cingulate cortex function and superior corona radiata integrity) mediated the relationships of serum CRP with sustained attention and sleep structure in MDD patients. Our findings may not only confirm the role of inflammation in the neuropathology of MDD, but also inform a novel conceptualization of targeting inflammatory processes to treat this disorder.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.